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Abstract 
Glaesserella parasuis strains were characterized by serotyping PCR, vtaA virulence marker Leader Sequence (LS)‑PCR, 
clinical significance, and geographic region. Overall, the serovars 4, 5/12, 7, 1, and 13 were the most commonly 
detected. Serovars of greatest clinical relevance were systemic isolates that had a higher probability of being serovar 
5/12, 13, or 7. In comparison, pulmonary isolates had a higher likelihood of being serovars 2, 4, 7, or 14. Serovars 5/12 
and 13 have previously been considered disease‑associated, but this study agrees with other recent studies showing 
that serovar 7 is indeed associated with systemic G. parasuis disease. Serovar 4 strains illustrated how isolates can have 
varying degrees of virulence and be obtained from pulmonary, systemic, or nasal sites. Serovars 8, 9, 15, and 10 were 
predominantly obtained from nasal samples, which indicates a limited clinical significance of these serovars. Addi‑
tionally, most internal G. parasuis isolates were classified as virulent by LS‑PCR and were disease‑associated isolates, 
including serovars 1, 2, 4, 5/12, 7, 13, and 14. Isolates from the nasal cavity, including serovars 6, 9, 10, 11, and 15, were 
classified as non‑virulent by LS‑PCR. In conclusion, the distribution of G. parasuis serovars remains constant, with few 
serovars representing most of the strains isolated from affected pigs. Moreover, it was confirmed that the LS‑PCR can 
be used for G. parasuis virulence prediction of field strains worldwide.
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Introduction
Glaesserella parasuis is an important pathogen of swine 
and remains one of the most important bacterial causes 
of mortality in swine production worldwide. Clini-
cal signs of infected pigs range from fever, respiratory 
signs, and swollen joints with lameness, to central nerv-
ous signs, and sudden death. Chronic infections are also 
associated with reduced growth rates and food conver-
sion efficiencies. The main pathological findings include 
fibrinopurulent polyserositis, polyarthritis, and meningi-
tis, commonly known as Glässer’s disease [1].
Glässer’s disease is considered one of the most preva-
lent swine bacterial infections worldwide [2]. Reliance 
on prophylactic or strategic medication to control this 
disease is an ongoing concern regarding the emergence 
of antimicrobial resistance [3–6]. Bacterins and a live 
attenuated vaccine are commercially available. However, 
G. parasuis is a highly diverse pathogen, with still poorly 
known cross-protection against disease-causing field 
strains [7, 8]. In many countries, autogenous bacterins 
are also produced.
G. parasuis is also a commensal of the upper respira-
tory tract (URT) [9]. Disease outbreaks are associated 
with the introduction of novel G. parasuis strains into an 
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immunologically naïve pig population, typically through 
the mixing of pigs from different sources. Other predis-
posing factors include poor management, high stocking 
density, inadequate ventilation, and coinfections with 
other respiratory pathogens [10, 11].
Epidemiological investigation of G. parasuis-associated 
disease, and preventive health management, relies on 
identifying specific G. parasuis serovars colonizing and 
or causing illness. Fifteen G. parasuis serovars that dif-
fer in virulence have been described [12, 13]. However, 
healthy pigs can carry serovars commonly isolated from 
systemic sites in the URT, alongside isolates of serovars 
rarely identified in clinical disease [14, 15].
This broad diversity within the G. parasuis species in 
the field requires surveillance tools to detect disease-rele-
vant strains. Whole-genome sequencing enabled detailed 
analysis of the capsule loci of G. parasuis [16] and the 
development of a multiplex serotyping PCR [17, 18]. This 
PCR reaction uses specific primers based on serovar-spe-
cific variations on the capsule loci, capable of discrimi-
nating 14 of the 15 recognized G. parasuis serovars but 
not serovars 5 and 12. A new G. parasuis serovar-specific 
PCR scheme containing primers that differentiate sero-
vars 5 and 12 was subsequently described [19]. However, 
the primer for serovar 12 is based on a hypothetical gene, 
and further investigations are warranted.
In parallel to molecular serotyping, novel PCR methods 
were developed to track virulence markers for G. par-
asuis isolates. A group of specific virulence-associated 
genes, named virulence-associated trimeric autotrans-
porters (vtaA) group 1-translocator, were associated with 
virulent G. parasuis strains [20]. Additionally, two differ-
ent leader sequences were detected in the vtaA genes. A 
test for predicting the virulence potential of G. parasuis 
strains was developed based on the leader sequence of 
the vtaA genes, called LS-PCR [21].
Such epidemiological investigations are essential 
for designing preventive health programs, supporting 
vaccine candidate selection, improving pig flow manage-
ment, and limiting the reliance on prophylactic antimi-
crobials. This study’s objective was to characterize strains 
of G. parasuis from top pork-producing countries in 
terms of the relative geographic prevalence of molecular 
serovars and their relationship with vtaA markers.
Materials and methods
Isolate collection
The 950 G. parasuis isolates in this collection originated 
from pigs from different geographical regions; USA 
(n = 223 from 15 different states), Europe (n = 436 from 
13 different Member States), China (n = 167 from 12 dif-
ferent provinces), Vietnam (n = 56, from two provinces), 
and Canada (n = 68, from Quebec) (Figure 1, Additional 
file 1). The dates of collection of isolates ranged between 
2014–2018 for USA isolates, 2000–2006, 2015–2016 or 
unknown for European isolates, 1999–2007 or unknown 
for Chinese isolates, 2017 for Vietnamese isolates, and 
2017–2019 for Canadian isolates (Additional file 1). The 
G. parasuis isolates used in this study came from diag-
nostic and research laboratories that are national leaders 
in their own countries regarding swine diseases, includ-
ing Glässer’s disease. Only isolates with a designated 
serovar were included. However, more specific informa-
tion regarding the clinical history and epidemiology was 
not available for most isolates and was not included in 
this study.
Data for US isolates (n = 223) were obtained from the 
Iowa State University Veterinary Diagnostic Laboratory 
(ISU VDL), where isolates were confirmed as G. parasuis 
using Bruker matrix-assisted laser desorption time-of-
flight mass spectrometry (MALDI_TOF MS). Data for 
Canadian strains (n = 66) were obtained from the Diag-
nostic Laboratory of the Faculty of Veterinary Medicine 
of the University of Montreal (DLFVMUM), where iso-
lates were also firstly identified by MALDI_TOF MS 
and confirmed by PCR [22]. Data for European isolates 
Figure 1 Distribution of Glaesserella parasuis isolates per country.
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were obtained from Spain (IRTA-CReSA, n = 275) and 
Germany (IVD Innovative Veterinary Diagnostics (IVD 
GmbH), (n = 165) and represented 13 different member 
states. Confirmation of G. parasuis by both laborato-
ries was achieved by PCR [22]. Data for Chinese isolates 
(n = 167) and Vietnamese isolates (n = 56) were obtained 
from Huazhong Agricultural University Veterinary Diag-
nostic Laboratory. The Chinese and Vietnamese isolates 
were firstly identified with biochemical tests [23] and 
confirmed by 16S rRNA PCR [25].
Metadata for a subset of these isolates included isola-
tion site, year of isolation, and country of origin (Addi-
tional file  1). Metadata for the strains were used to 
classify isolates considering clinical (internal organs) and 
non-clinical (URT) source when such information was 
available. Further classification was performed consid-
ering clinical (internal) isolates that were obtained from 
systemic sites or pulmonary (lungs) and non-clinical 
(URT) origins. G. parasuis strains isolated from internal 
organs other than the lungs, such as pleura, pericardium, 
peritoneum, joint, and meninges, were considered sys-
temic strains. All URT strains in this study were isolated 
from nasal cavities.
Serotyping PCR
Serotyping PCR was undertaken by each participating 
laboratory with some laboratory-specific amendments. 
DNA extraction was achieved by standard methods; typi-
cally, a loopful of bacterial colonies were removed from 
growth media and suspended in 300 µL of 0.01 M ster-
ile phosphate-buffered saline (pH 7.4) without calcium 
and magnesium (GIBCO/Life Technologies Corporation, 
Carlsbad, CA, USA) and vortexed. Bacterial DNA was 
extracted with the MagMAX™ Viral DNA/RNA Isolation 
Kit (Life Technologies, Carlsbad, CA, USA) using extrac-
tion protocol per manufacturer instructions.
All participating laboratories conducted the serotyping 
PCR as previously described [17] with some (ISU VDL, 
DLFVMUM, and IVD) using the modifications made by 
Lacouture et al. [18].
Briefly, each PCR reaction (one for each of the primer 
mixtures) consisted of 12.5  µL of 2 × Multiplex PCR 
Master Mix (Qiagen, Hilden, Germany), 2.5 µL of the 
100 nmol  1–1 of primer mix 1, 2 or 3, 8 µL of nuclease-
free water, and 2 µL of extracted DNA. The reaction was 
run using the following conditions: first cycle at 95 °C for 
15 min, followed by 40 cycles of 94 °C for 30 s, 58 °C for 
90 s, and 72 °C for 90 s. This was followed by one cycle at 
72 °C for 10 min. Electrophoresis and visualization of the 
PCR products were performed using QIAxcel Capillary 
Electrophoresis with screen gel software (Qiagen).
For isolates obtained by IRTA-CReSA, PCR conditions 
were amended using the same primers as Howell et  al. 
[17], but these were tested individually as follows: 94 °C 
for 5 min, followed by 30 cycles of 94 °C for 30 s, 55 °C 
for 30 s, and 72 °C for 60 s, and final extension of 72 °C 
for 7  min. PCR products were visualized by agarose gel 
electrophoresis.
Virulence gene PCR (LS‑PCR)
Isolates from North America and Europe were tested 
using a PCR to detect the leader sequence (LS) of the 
vtaA genes domain as a diagnostic tool to predict G. par-
asuis virulence [21]. Briefly, the PCR reaction consisted 
of 12.5  µL of 2 × Multiplex PCR Master Mix (Qiagen), 
1 µL of the 100 nmol  1–1 of each primer, 4.5 µL of nucle-
ase-free water, and 2 µL of extracted DNA in a final vol-
ume of 25 μL. Cycling conditions were 15 min at 95  °C, 
followed by 30 cycles of 45 s at 94 °C, 45 s at 52 °C and 
1 min at 72 °C, then a final incubation at 72 °C for 10 min.
Statistical analysis
Associations between serovars, sample site, country of 
isolation, and LS-PCR results were calculated using Chi-
square and Fisher’s exact tests. A multinomial logistic 
regression model was fit to compare the sample site and 
serovar classification to the reference (untypeable or NT) 
serovar. All tests were 2-sided, and a p-value of lower 
than 0.05 was defined as indicating a significant differ-
ence. All analyses were completed using SAS version 9.4.
Results
Distribution of G. parasuis serovars
Most of the G. parasuis isolates (886/950, 93.3%), were 
typeable by serotyping PCR, and the remaining 64 
(9.7%) were identified as non-typeable (NT). All 15 sero-
vars were identified. Serovars 4 (17.4%), 5/12 (16.8%), 
7 (11.4%), 1 (10.7%), and 13 (9.1%) were the most com-
monly detected serovars across the participating regions 
(Figure 2, Table 1, Additional files 2, 3, 4).
Internal isolates
Information on the site of origin for each isolate was 
available for 834 of the total 950 G. parasuis isolates, 
allowing classification of G. parasuis strains as either 
nasal or internal (Table  2). Internal isolates represented 
81.1% (676/834) of all isolates for which an attributable 
sample site was recorded (Table 2). The most frequently 
identified serovars from internal locations included sero-
vars 4, 5/12, 1, 7, and 13 in descending order, with sero-
vars 4 and 5/12 being similarly represented, at 19.2 and 
18.2%, respectively.
Further classification of internal isolates into pul-
monary and systemic was possible for a subset of 519 
of these isolates. Almost sixty percent of these further 
classified isolates (307/519, 59.2%) were obtained from 
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pulmonary sites, while 40.8% (212/519) were of sys-
temic origin (Table 2). Serovar 4 strains were more fre-
quently isolated from lung samples than serovar 5/12 
strains (27 and 14.7%, respectively). In contrast, when 
considering systemic isolates separately, the percentage 
of serovar 5/12 strains was higher compared with sero-
var 4 (22.2 and 13.7%, respectively) (Table 2). Likewise, 
both serovars 7 and 13 were more frequently detected 
within internal samples, than nasal samples. However, 
while serovar 7 was similarly represented within both 
pulmonary and systemic collections (12.1 and 15.6% of 
each collection, respectively), the percentage of serovar 
13 strains was higher in the systemic collection com-
pared with the pulmonary one (14.2 and 9.1%, respec-
tively) (Table 2).
Clinically relevant serovars from internal sites, such 
as serovars 4, 5/12, 7, 1, and 13, were among the six 
serovars more frequently observed in North America 
and Europe, with similar distribution among systemic 






























Figure 2 Frequency distribution of Glaesserella parasuis serovars identified by PCR for all of the isolates in the present study.
Table 1 Number and percentage of Glaesserella parasuis serovars per country or region.
¶ Sum of number of serovars in each row
§ Sum of number of serovars in each column
Serovar USA/% Canada/% Europe/% China/% Vietnam/% Total¶
1 32/14.3 4/5.9 53/12.2 12/7.2 1/1.8 102
2 28/12.6 4/5.9 13/3 8/4.8 13/23.2 66
3 0/0 1/1.5 0/0 5/3 0/0 6
4 53/23.8 8/11.8 75/17.2 19/11.4 10/17.9 165
5/12 28/12.6 21/30.9 60/13.8 36/21.6 15/26.8 160
6 2/0.9 1/1.5 12/2.8 12/7.2 1/1.8 28
7 41/18.4 11/16.2 51/11.7 4/2.4 1/1.8 108
8 0/0 2/2.9 21/4.8 13/7.8 1/1.8 37
9 0/0 0/0 26/6 7/4.2 6/10.7 39
10 0/0 0/0 18/4.1 6/3.6 7/12.5 31
11 0/0 0/0 3/0.7 1/0.6 0/0 4
13 23/10.3 6/8.8 51/11.7 6/3.6 0/0 86
14 12/5.4 2/2.9 11/2.5 8/4.8 0/0 33
15 1/0.4 1/1.5 18/4.1 1/0.6 0/0 21
NT 3/1.3 7/10.3 24/5.5 29/17.4 1/1.8 64
Total§ 223/100 68/100 436/100 167/100 56/100 950
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isolates, serovar 5/12 was the most prevalent, followed 
by serovars 4 and 2 (Table 3).
The highest proportion of untypable internal isolates 
(18.5%, 29/157) was found among Chinese isolates, 
while only 1.4% (3/210) of USA internal isolates were 
untypable (Table 3).
Nasal isolates
Nasal isolates represented 18.1% (158/834) of all iso-
lates for which an attributable sample site was recorded 
and belonged to a variety of serovars, especially sero-
vars 8 (12%), 1 (12%), 4 (11.4%), 9 (11.4%), 15 (10.8%) 
and 10 (9.5%) (Table  2). While serovars 1 and 4 were 
more consistently found within systemic or pulmo-
nary sites, serovars 8, 9, 15, and 10 were predominantly 
obtained from nasal samples (Table 2).
Most of the nasal isolates in this study were obtained 
from Europe (76.6%, 121/158) (Table 6). The most prev-
alent nasal serovars in Europe were 8, 15, 1, 4, 9, and 10. 
Most of these serovars were not prevalent among inter-
nal samples, except for serovars 1 and 4, which were 
also prevalent among pulmonary and systemic sites 
(Tables 3, 4, 5, 6).
Besides these European nasal isolates, 35 G. paras-
uis nasal isolates were from Asian countries, includ-
ing 25 from Vietnam and ten from China. Most of 
the nasal isolates from China were either from sero-
var 5/12 or 1, while most of the nasal isolates from 
Vietnam were from serovars 2, 9, 4, and 10 (Tables 6). 
However, only serovars 1 and 9 were predominantly 
higher among nasal isolates. The other serovars 
were also frequently found among internal isolates 
(Table 3).
Table 2 Number and percentage of Glaesserella parasuis 
serovars per site of isolation.
*Information was available for 519 internal isolates, which were divided into 
pulmonary and systemic
¶ Sum of nasal and internal isolates in each row
§ Sum of values in each column
Serovar Nasal/% Internal/% Pulmonary*/% Systemic*/% Total¶
1 19/12 75/11.1 37/12.1 29/13.7 94
2 6/3.8 53/7.8 31/10.1 14/6.6 59
3 0/0 6/0.9 0/0 1/0.5 6
4 18/11.4 130/19.2 83/27 29/13.7 148
5/12 13/8.2 124/18.3 45/14.7 47/22.2 137
6 7/4.4 19/2.8 2/0.7 5/2.4 26
7 8/5.1 74/10.9 37/12.1 33/15.6 82
8 19/12 16/2.4 3/1 1/0.5 35
9 18/11.4 17/2.5 6/2 4/1.9 35
10 15/9.5 14/2.1 7/2.3 1/0.5 29
11 0/0 4/0.6 2/0.7 1/0.5 4
13 8/5.1 63/9.3 28/9.1 30/14.2 71
14 1/0.6 30/4.4 15/4.9 7/3.3 31
15 17/10.8 2/0.3 0/0 1/0.5 19
NT 9/5.7 49/7.2 11/3.6 9/4.2 58
Total§ 158/100 676/100 307/100 212/100 834
Table 3 Number and percentage of Internal Glaesserella parasuis serovars per country or region.
¶ Sum of number of serovars in each row.
§ Sum of number of serovars in each column.
Serovar USA/% Canada/% Europe/% China/% Vietnam/% Total¶
1 31/14.8 3/6.7 32/13.7 9/5.7 0/0 75
2 27/12.9 3/6.7 8/3.4 8/5.1 7/22.6 53
3 0/0 1/2.2 0/0 5/3.2 0/0 6
4 51/24.3 1/2.2 54/23.2 18/11.5 6/19.4 130
5/12 28/13.3 15/33.3 35/15 32/20.4 14/45.2 124
6 2/1 1/2.2 4/1.7 12/7.6 0/0 19
7 34/16.2 8/17.8 28/12 4/2.5 0/0 74
8 0 / 1/2.2 3/1.3 12/7.6 0/0 16
9 0/0 0/0 10/4.3 7/4.5 0/0 17
10 0/0 0/0 4/1.7 6/3.8 4/42.9 14
11 0/0 0/0 3/1.3 1/0.6 0/0 4
13 22/10.5 4/8.9 32/13.7 5/3.2 0/0 63
14 12/5.7 1/2.2 9/3.9 8/5.1 0/0 30
15 0/0 1/2.2 0/0 1/0.6 0/0 2
NT 3/1.4 6/13.3 11/4.7 29/18.5 0/0 49
Total§ 210/100 45/100 233/100 157/100 31/100 676
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Association between Glaesserella parasuis serovars and site 
of isolation
Results of the chi-square analysis showed an associa-
tion between sample type (nasal/internal) and serovar 
(p < 0.001). A multinomial logistic regression model was 
further used to predict serovar classification based on 
sample type. Given the sample type (nasal/internal), sam-
ples collected from the nasal cavity had a higher prob-
ability of being of serovars 8, 9, 10, or 15 (p < 0.05), but 
no association was found between serovar and internal 
samples, during this initial analysis.
Using the same model, internal isolates were classified 
as either pulmonary or systemic and compared against 
nasal isolates for the subsequent analysis. Given the 
sample type, systemic isolates had a higher probability 
of being of serovar 5/12, 13, or 7 compared to the nasal 
sample collection (p < 0.01). In comparison, pulmonary 
isolates had a higher likelihood of being serovars 2, 4, 7, 
or 14 (p < 0.01). No statistical significance was observed 
when comparing systemic and pulmonary isolates. These 
results agree with Olvera et  al. [20], where pulmonary 
isolates could be either virulent or non-virulent since 
the lung can be populated by upper respiratory tract 
commensal microbiota and strains that harbor certain 
virulence factors that enable them to survive the lung 
defenses and invade systemically. As shown in Table  2, 
14/53 and 7/31 of serovars 2 and 14, respectively, were 
also found on systemic sites.
Table 4 Number and percentage of Pulmonary  Glaesserella 
parasuis serovars per country or region.
¶ Sum of number of serovars in each row.
§ Sum of number of serovars in each column.
There is no information whether Canadian and Chinese internal isolates 
originated from pulmonary sites.
Serovar USA/% Europe/% Vietnam/% Total¶
1 15/11.9 22/14.7 0/0 37
2 17/13.5 7/4.7 7/22.6 31
4 39/31 38/25.3 6/19.4 83
5/12 15/11.9 16/10.7 14/45.2 45
6 1/0.8 1/0.7 0/0 2
7 19/15.1 18/12 0/0 37
8 0/0 3/2 0/0 3
9 0/0 6/4 0/0 6
10 0/0 3/2 4/12.9 7
11 0/0 2/1.3 0/0 2
13 7/5.6 21/14 0/0 28
14 11/8.7 4/2.7 0/0 15
NT 2/1.6 9/6 0/0 11
Total§ 126/100 150/100 31/100 307
Table 5 Number and percentage of Systemic Glaesserella 
parasuis serovars per country or region.
¶ Sum of number of serovars in each row.
§ Sum of number of serovars in each column.
There is no information whether Asian internal isolates originated from systemic 
sites.
Serovar USA/% Canada/% Europe/% Total¶
1 16/19 3/6.7 10/12 29
2 10/11.9 3/6.7 1/1.2 14
3 0/0 1/2.2 0/0 1
4 12/14.3 1/2.2 16/19.3 29
5/12 13/15.5 15/33.3 19/22.9 47
6 1/1.2 1/2.2 3/3.6 5
7 15/17.9 8/17.8 10/12 33
8 0/0 1/2.2 0/0 1
9 0/0 0/0 4/4.8 4
10 0/0 0/0 1/1.2 1
11 0/0 0/0 1/1.2 1
13 15/17.9 4/8.9 11/13.3 30
14 1/1.2 1/2.2 5/6 7
15 0/0 1/2.2 0/0 1
NT 1/1.2 6/13.3 2/2.4 9
Total§ 84/100 45/100 83/100 212
Table 6 Number and percentage of Nasal Glaesserella 
parasuis serovars per country or region.
¶ Sum of number of serovars in each row.
§ Sum of number of serovars in each column.
There were no nasal G. parasuis isolates submitted from Canada.
Serovar USA/% Europe/% China/% Vietnam/% Total¶
1 1/50 14/11.6 3/30 1/4 19
2 0/0 0/0 0/0 6/24 6
4 1/50 12/9.9 1/10 4/16 18
5/12 0/0 8/6.6 4/40 1/4 13
6 0/0 6/5 0/0 1/4 7
7 0/0 7/5.8 0/0 1/4 8
8 0/0 17/14 1/10 1/4 19
9 0/0 12/9.9 0/0 6/24 18
10 0/0 12/9.9 0/0 3/12 15
13 0/0 7/5.8 1/10 0/0 8
14 0/0 1/0.8 0/0 0/0 1
15 0/0 17/14 0/0 0/0 17
NT 0/0 8/6.6 0/0 1/4 9
Total§ 2/100 121/100 10/100 25/100 158
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Association between Glaesserella parasuis serovars 
and LS‑PCR result
G. parasuis isolates were classified as potentially viru-
lent based on the presence or absence of specific leader 
sequences within their vtaA genes, using multiplex LS-
PCR. Within this G. parasuis collection, 727 isolates were 
tested by LS-PCR among North American and Euro-
pean isolates (Table 7). Overall, 85.7% (623/727) of the G. 
parasuis isolates were classified as virulent by LS-PCR, 
14.3% (104/727) were classified as non-virulent by LS-
PCR, and 223 isolates were not tested (Table 7).
Most of the disease-associated isolates, including 1, 2, 
4, 5/12, 7, 13, and 14, were considered virulent by LS-
PCR, with few exceptions where these virulent serovars 
were deemed to be non-virulent by LS-PCR (10/578) 
(Table 7). In contrast, most of the isolates from the nasal 
cavity, including serovars 6, 9, 10, and 15, were consid-
ered non-virulent by LS-PCR (Table 8), with a significant 
association between serovar and classification as virulent 
or non-virulent by LS-PCR (p < 0.001). Further analy-
sis was performed within each serovar to evaluate the 
association of virulent and non-virulent strains with the 
site of isolation. A significant association was found for 
serovars 5/12 and 7, which had a higher chance of being 
virulent and from internal sites (systemic or pulmonary). 
Contrarily, serovar 10 had a higher chance of being non-
virulent and from a nasal site (Table 8).
Discussion
Serotyping has been a necessary means of character-
izing G. parasuis isolates. Using a novel serotyping 
PCR method [17, 18], we described the distribution of 
G. parasuis serovars globally and within a geographic 
region. The data collected in this study are from different 
Table 7 Number and percentage of virulent and non‑
virulent isolates within the same serovar.
¶ Sum of number of serovars in each row.
§ Sum of number of serovars in each column.




Not Tested by 
LS‑PCR/%
Total¶
1 89/87.3 0/0 13/12.7 102
2 44/66.7 1/1.5 21/31.8 66
3 0/0 1/16.7 5/83.3 6
4 136/82.4 0/0 29/17.6 165
5/12 106/66.3 3/1.9 51/31.9 160
6 4/14.3 11/39.3 13/46.4 28
7 101/93.5 2/1.9 5/4.6 108
8 0/0 23/62.2 14/37.8 37
9 6/15.4 20/51.3 13/33.3 39
10 2/6.5 16/51.6 13/41.9 31
11 3/75 0/0 1/25 4
13 77/89.5 3/3.5 6/7 86
14 25/75.8 0/0 8/24.2 33
15 3/14.3 17/81 1/4.8 21
NT 27/42.2 7/10.9 30/46.9 64
Total§ 623/65.6 104/10.9 223/23.5 950
Table 8 Distribution of Glaesserella parasuis serovars by site 
of isolation and LS‑PCR results.
*Not Tested: All isolates from this serovar had the same LS-PCR result.
P-value < 0.05 was considered significant.
LS‑PCR Systemic Pulmonary Nasal P‑value
Serovar 1 Virulent 29 37 15
Non-Viru-
lent
0 0 0 Not Tested*
Serovar 2 Virulent 14 23 0
Non-Viru-
lent
0 1 0 0.439
Serovar 3 Virulent 0 0 0
Non-Viru-
lent
1 0 0 Not Tested
Serovar 4 Virulent 14 23 0
Non-Viru-
lent
0 1 0 0.439
Serovar 
5/12
Virulent 47 30 6
Non-Viru-
lent
0 1 2 0.002
Serovar 6 Virulent 1 0 2
Non-Viru-
lent
4 2 4 0.612
Serovar 7 Virulent 33 37 5
Non-Viru-
lent
0 0 2 0.000
Serovar 8 Virulent 0 0 0
Non-Viru-
lent
1 3 17 Not Tested
Serovar 9 Virulent 0 3 1
Non-Viru-
lent
4 3 11 0.056
Serovar 10 Virulent 1 1 0
Non-Viru-
lent
0 2 12 0.007
Serovar 11 Virulent 1 2 0
Non-Viru-
lent
0 0 0 Not Tested
Serovar 13 Virulent 30 26 6
Non-Viru-
lent
0 2 1 0.188
Serovar 14 Virulent 7 15 1
Non-Viru-
lent
0 0 0 Not Tested
Serovar 15 Virulent 0 0 2
Non-Viru-
lent
1 0 15 0.716
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diagnostic laboratories and research centers. Even 
though they serve as centers of expertise on the diagnosis 
of swine diseases, the dataset used in this study is lim-
ited to isolates available in these laboratories and, there-
fore, do not represent a true prevalence of G. parasuis 
serovars. Additionally, some of the strains from Europe 
(57/436) and China (167/223) were isolated more than 
ten years ago or have an unknown date of isolation. Thus, 
the actual distribution (prevalence) of G. parasuis sero-
vars is still unknown. Even though our data do not rep-
resent prevalence, most of these isolates originate from 
field cases and reflect strains frequently found in disease-
associated cases, and thus useful information for swine 
practitioners and researchers.
The serovars’ overall distribution varied slightly among 
countries, and four serovars (1, 4, 5/12, and 7) accounted 
for half of all isolates. Serovars 4 and 5/12, in particular, 
were consistently represented across all regions in this 
study and previous studies [13, 22–28].
The serovars of utmost clinical significance were identi-
fied in samples from internal sites (serovars 4, 5/12, 1, 7, 
and 13) in this study. These serovars have been previously 
considered disease-associated [12, 13, 22–30]. Variable 
sample sizes limited our ability to discern significant dif-
ferences in serovar prevalence at the country level. The 
relative scarcity of serovar 4 isolates among Canada’s 
internal samples was notable, and serovars 1, 7, and 13 
appeared relatively similarly scarce among internal sam-
ples from China and Vietnam.
An important finding in this present study and other 
recent studies [28–30] was that serovar 7 is a significant 
disease-associated serovar of G. parasuis. In this study, 
serovar 7 was assigned to 10.9% of all internal samples 
(ranked  4th most prevalent serovar) and 15.6% of all 
systemic isolates (ranked second most prevalent sero-
var). Serovar 7 was initially found non-virulent by intra-
peritoneal challenge [12], and it was the most prevalent 
serovar identified from the URT of healthy pigs in China 
[14]. Conversely, a serovar 7 field strain was able to cause 
disease in one snatch-farrowed colostrum-deprived pig 
when inoculated intranasally and was consistently iso-
lated from pulmonary and systemic locations from pigs 
affected by Glasser’s disease in Germany [28]. Addition-
ally, the serovar 7 reference strain 174 caused disease in 
colostrum-deprived and commercial pigs after experi-
mental inoculation [29, 30], demonstrating this serovar’s 
pathogenic potential [31].
Based on their detection in fewer than 1% of all inter-
nal samples, the least clinical significance serovars were 
serovars 3, 11, and 15. Serovars 3 and 11 were previously 
considered non-virulent [12]. Still, the apparent limited 
clinical significance of serovar 15 contradicted previous 
findings [12], highlighting the limitations of small-scale 
challenge studies as indicators of virulence. Isolates of 
serovar 10 have been reported as disease and non-disease 
associated [31]. Still, while the present study found sero-
var 10 in 9.9% of nasal samples from Europe (the region 
supplying the most significant bulk of nasal samples), it 
was found in only 1.7% of internal samples from Europe – 
along with a small cluster of internal isolates from China 
and Vietnam. Thus, the present study indicates only lim-
ited significance for this serovar.
Nevertheless, pigs harbor various G. parasuis strains 
in their URT, and potentially pathogenic serovars can 
be isolated from the URT of healthy pigs [9, 14]. In this 
study, URT isolates originated mainly from Europe and 
Asia, representing 16.6% of this study’s collection. Sero-
vars 6, 8, 9, 10, and 15 were amongst the most commonly 
identified (43.6%) in the URT. In comparison, these 
serovars represented only 7.2% of all internal isolates. 
Serovars 10 and 15 have been traditionally considered 
virulent, even though they are not prevalent as disease-
associated serovars worldwide, and were classified as 
non-virulent by the LS-PCR. Interestingly, serovars 6 and 
8 Asian isolates were also frequently isolated from Chi-
nese samples’ internal sites, representing an increase of 
more virulent strains belonging to these serovars in Asia.
Different pathogenic properties have also been 
described for G. parasuis serovar 4 strains. The refer-
ence isolate for serovar 4 was initially isolated from the 
nose of a healthy pig and considered mildly virulent 
[12]. In our study, serovar 4 isolates were mainly associ-
ated with pulmonary sites (83/130, 64%), followed by 
systemic (29/130) and nasal sites (18/130). In an earlier 
study, North American isolates of serovar 4 were mainly 
isolated from lung samples of pigs with pneumonia and 
other systemic sites, but not from URT samples [22]. 
When two serovar 4 European field isolates were used to 
infect pigs experimentally, one could reproduce Glasser’s 
disease, while the other could not [31]. These results are 
consistent with other reports showing serovar 4 isolates 
clustering with virulent and non-virulent genotypes [31–
33]. These findings illustrate how isolates of the same 
serovar can have different degrees of virulence. Addition-
ally, some G. parasuis serovars’ virulence may have been 
wrongly assigned by the Kielstein and Rapp-Gabrielson 
scheme [12].
Glasser’s disease is a complex multifactorial disease, 
and several different putative virulence genes have been 
identified [34–37]. Still, little experimental data is avail-
able to correlate these virulence genes with clinical dis-
ease. However, empirical evidence exists, demonstrating 
the group 1 vtaA genes’ role in G. parasuis virulence [21, 
38, 39]. Therefore, to help identify virulent G. parasuis 
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strains, a new PCR, based on the leader sequence of the 
vtaA genes, was developed [21].
In the present study, most internal isolates were iden-
tified as virulent by LS-PCR, while most nasal isolates 
were non-virulent. Our results agree with previous 
reports [25, 28, 39–41] and supported our disease asso-
ciation observations for serovar 7 isolates. In our study, 
most serovar 7 (75/77, 97.4%) strains were internal and 
classified as virulent by the LS-PCR. Only two serovar 
7 LS-PCR negatives were found in the collection, and 
these were from nasal samples. In  vitro analysis was 
not performed in this study to further characterize the 
virulence of the strains. Previous genome analysis per-
formed on a serovar 7 reference strain classified as vir-
ulent by LS-PCR, but susceptible to both phagocytosis 
and serum demonstrated a reduction in the number of 
vtaAs in that strain, which may represent a strain with 
an intermediate phenotype [21].
Nevertheless, some discordant results were also 
found within the LS-PCR data. We found that a small 
number of isolates from typically non-disease-asso-
ciated serovars (such as 6, 8, and 9), and classified as 
non-virulent by LS-PCR, were recovered from systemic 
sites. In this case, other environmental factors or coin-
fections could be responsible for creating the necessary 
conditions for less virulent strains to invade systemi-
cally [21, 31, 40]. Even though vtaA genes are positively 
correlated with G. parasuis virulent strains and can be 
used as a predictor of virulence, other factors may also 
be necessary for disease development [25, 32, 40].
In conclusion, the overall distribution of G. parasuis 
serovars remains predominantly constant over the past 
20  years, with few serovars representing most of the 
strains isolated from Glasser’s disease-affected pigs and 
noting the confirmation of serovar 7 as a globally rel-
evant serovar. Even though the serovar and virulence 
relationship is not definitive, serotyping is still suitable 
for the epidemiological characterization of G. parasuis 
in pig farms, helping implement more adequate con-
trol measures, such as selecting isolates to be included 
in vaccines. When serotyping is not available, the site 
of isolation can become crucial for screening disease-
associated isolates since systemic strains are likely the 
ones that possess the necessary virulent mechanisms 
for disease development. To date, vtaA genes are the 
most well-characterized G. parasuis virulence fac-
tors. This survey of global G. parasuis isolates confirms 
that the LS-PCR is useful for G. parasuis virulence 
prediction.
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